Since almost half of human cancers have TP53 mutations and mutation of one allele of p53 can promote carcinogenesis due to the dominant negative effect, the best strategy to treat mutp53-containing cancer is to eliminate mutp53 and restore the tumor-suppressive function of wtp53. This evidence concerns the gene TP53 and neoplasm.